TMCI Stock Analysis: Buy, Sell, or Hold?
TMCI - Treace Medical Concepts, Inc. Common Stock
$1.45
0.04 (2.84%)
▲
5d:
+13.28%
30d:
-1.36%
90d:
-40.82%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
TMCI is down 6.0% this week, but smart money is accumulating calls. Top strike: $2.5 2026-03-20 with 633 OI. Call ratio: 100% View Scanner →
Strength: 8.0/10
Get Alerted When TMCI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TMCI shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: TMCI shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: TMCI is currently trading at $1.45, which is considered fair relative to its 30-day fair value range of $1.23 to $1.72.
Technical Outlook: Technically, TMCI is in a strong downtrend. The price is approaching resistance at $1.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TMCI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.25 (+193.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TMCI is in a strong downtrend. The price is approaching resistance at $1.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TMCI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.25 (+193.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.23 -
$1.72
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 193.1% below Wall St target ($4.25)
Fair Price Analysis
30-Day Fair Range
$1.23 -
$1.72
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.17
Resistance Level
$1.46
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.61
Wall Street Target
$4.25
(+193.1%)
Revenue Growth (YoY)
-9.0%
Profit Margin
-27.7%
Share & Embed Analysis
Last updated: April 04, 2026 8:14 AM ET
Data refreshes hourly during market hours. Next update: 9:14 AM
Data refreshes hourly during market hours. Next update: 9:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TMCI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 56 HOLD |
